Procalcitonin applications management in the Biochemistry Emergency Laboratory
Main Article Content
Abstract
Procalcitonin (PCT) is one of the best diagnostic markers of bacterial infection. PCT results greater than 0.5 mg/L are indicative of sepsis; its levels being related to the severity and mortality of the infectious condition. All requests with a joint application for C-reactive protein (CRP) and PCT during 2017 were analyzed. In most cases, although CRP was higher than the established cut-off point, PCT values were less than 0.5 mg/L. The results showed that, if PCT was performed exclusively in patients with CRP greater than or equal to 20 mg/L, all patients susceptible to septic processes could be recruited. Because of this, we propose that PCT should not be performed if there is no CRP greater than 20 mg/L, except in cases where there is clinical suspicion of sepsis, in neonates and in samples from the Intensive Care Unit in which the determination would always be made. In the months studied, 21.53% of PCT applications should have been canceled. This would have meant not performing unnecessary tests and a better use of the resources present in the Biochemistry Emergency Laboratory.
References
infection and sepsis: clinical utility and limitations. Critical Care Medicine, 36(3), 941-
952.
Caw, A., Covfan, R.A., O’Reilly, D., Stewart M.J., y Shepherd, J. (2001). Bioquímica Clínica.
Barcelona: Harcourt.
Cuadra, R., Ramos, R., Moreno, M., Gómez, M., y Liétor, J.A. (2011). Sepsis grave y shock
séptico. Manual de Urgencias. Barcelona: Reverté.
Dellinger, R.P., Levy, M.M., Carlet, J.M., y Bion, J. (2008). Surviving Sepsis Campaign:
International guidelines for management of severe sepsis and septic shock: 2008.
Critical Care Medicine, 36(1), 296-327.
Dot, D., Guillén, E., Huguet, J., Marín, J.L., Noguera, A., Padrós, G.,… Velasco, J. (1999).
Magnitudes biológicas que tiene interés medir de modo urgente. Química Clínica, 18(5),
282-286.
Fuentes, X., Castiñeiras, M.J., y Queraltó, J.M. (1998). Bioquímica Clínica y Patología Molecular.
Barcelona: Reverté.
Julián, A., Palomo, M.J., Ortiz, R., Pedrosa, A., Parejo, R., y Salcedo, R. (2009). Utilidad de la
procalcitonina y la proteína C reactiva en el paciente con sepsis en urgencias.
Emergencias, 21, 23-27.
Pepys, M.B., y Hirschfield, G.M. (2003). C-reactive protein: a critical update. Journal of Clinical
Investigation, 111(12), 1805-1812.
Pérez, M., Palacios, A., Sauceda, A., Aguirre, J., y Franco J. (2015). Índice procalcitonina/proteína
C reactiva (PCT/PCR) como predictor de mortalidad en pacientes con choque séptico.
Revista de la Asociación Mexicana de Medicina Crítica y Terapia Intensiva, 29(2), 64-
69.
Prat, C., y Domínguez, J. (2004). Procalcitonina y marcadores de infección. Educación
Continuada. en el Laboratorio Clínico, 7, 38-43.
Prieto, J.M., y Yuste, J.R. (2010). Balcells. La clínica y el laboratorio: interpretación de análisis y
pruebas funcionales, exploración de los síndromes, cuadro biológico de las
enfermedades. Barcelona: Elsevier Masson.
Talan, D.A., Moran, G.J., y Abrahamian, F.M. (2008). Severe sepsis and septic shock in the
emergency department. Infectious Disease Clinics of North America, 22(1), 1-31.
Wilson, A.M., Ryan, M.C., y Boyle, A.J. (2006). The novel role of C-reactive protein in
cardiovascular disease: risk marker or pathogen. International Journal of Cardiology,
106(3), 291-297.